Health
Johnson & Johnson COVID-19 vaccine candidate enters late-stage trials | News – Daily Hive
One shot, instead of two.
Pharma giant Johnson & Johnson has announced its COVID-19 vaccine candidate has entered the late-stage trials.
The pharmaceutical company said about 45,000 participants are currently enrolled in the trials, with interim data expected by the end of January 2021.
If the Johnson & Johnson vaccine candidate proves effective, the company says it will submit an emergency use authorization application to the US Food and Drug Administration (FDA) in February.
Johnson & Johnson’s study, named Ensemble, was…
-
Noosa News13 hours agoFlatmates of missing teen Pheobe Bishop, 17, identified
-
Noosa News15 hours agoTully Sugar Mill celebrates 100 years of cane harvesting amid floods and cyclones
-
General19 hours agoOne person dead after house fire in Melbourne’s south-east
-
General12 hours agoPostecoglou’s message touches Blues AFL coach Voss after Spurs’ Europa League win